Thrasos wins new US patent
These compounds selectively activate the repair and regenerative effects of bone morphogenetic protein (BMP) without stimulating bone growth. This key differentiating factor offers significant potential for treating a

These compounds selectively activate the repair and regenerative effects of bone morphogenetic protein (BMP) without stimulating bone growth. This key differentiating factor offers significant potential for treating a

The FDA-cleared, clinically proven ThermaClear acne clearing device delivers a controlled, two-second pulse of targeted heat directly to individual pimples, attacking acne at its source, said Therative. The

ForHealth operations will continue from its US headquarters in Daytona Beach, Florida. The ForHealth acquisition adds IntelliFill iv and IntelliFlowRx to the existing Baxa products for pharmacy operations

Aridol will be a standardized test kit containing proprietary dry-powder mannitol (a naturally occurring sugar alcohol), prepared for delivery to the lungs using a proprietary hand-held inhaler. The

The Impact-DCM trial is evaluating the use of cardiac repair cells (CRCs), a mixture of stem and progenitor cells derived from a patient’s own bone marrow, for the

Serica Technologies, a medical device company, has received 510(k) clearance from the FDA for its SeriScaffold silk-based, long term bioresorbable scaffold technology. According to the company, the SeriScaffold

According to Microsoft, GSK will deploy its Business Productivity Online Suite, including Exchange Online, SharePoint Online, Office Communications Online, Office Live Meeting and the Deskless Worker Suite. Bill

The certificate of compliance has a five-year term and was issued by the State Food and Drug Administration following a site inspection. The good manufacturing practice (GMP) certification

The agreement is intended to increase the availability of the NESS L300 among all OPGA O&P members and to improve the care for persons with foot drop, suffering

Additionally, Hi-Tech may pay up to $4 million in performance incentives tied to future ECR product sales and profits. Under the terms of the acquisition Hi-Tech receives rights